Roivant Sciences News - May 2026
🟢 ROIV is trading 12% up today on a $2.25B Moderna settlement and Q4 earnings
ROIV is trading about 12% up at $31.50 in pre-market after reporting a massive $770.2M pre-tax gain from a $2.25B patent settlement with Moderna. • The...
Roivant's fourth quarter 2026 EPS beats on a $770.2M litigation gain, while key pipeline assets advance
Roivant reported fourth-quarter fiscal 2026 revenue of $2.52 million, below analyst estimates, while GAAP earnings per share from continuing operations was...
Roivant Sciences Ltd Q1 2026 Earnings Preview: What Analysts Expect on May 20, 2026
Wall Street expects Roivant Sciences to report consensus revenue of $3.68 million and an EPS of -$0.38, with the current stock price of $29.29 trading...